Status:
ACTIVE_NOT_RECRUITING
Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19
Lead Sponsor:
Linkoeping University
Collaborating Sponsors:
Region Östergötland
Conditions:
COVID-19
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry-based cohort study of all adult patients (≥18 years) admitted to Swedish Intensive Care Units with confirmed SARS-CoV-2 infection and COVID-19 disease during the first 2 months of t...
Detailed Description
Previous studies reporting outcomes for COVID-19 patients admitted to intensive care units (ICUs) have been hampered by right-censoring after short observation periods. None have reported 30-day morta...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years)
- COVID-19 disease
Exclusion
- No Swedish personal identity number
- 'Opt out' from Swedish Intensive Care Registry
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT04462393
Start Date
March 6 2020
End Date
December 31 2026
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesia and Intensive Care, Linkoeping University Hospital, Region Östergötland
Linköping, Östergötland County, Sweden, 50185